Realizing individualized cancer treatment through patient genome sequencing

Recent Publications

Kurata, M., Onishi, I., Takahara, T., Yamazaki, Y., Ishibashi, S., Goitsuka, R., Kitamura, D., Takita, J., Hayashi, Y., Largaesapda, D. A., Kitagawa, M. and Nakamura, T.
C/EBPβ induces B-cell acute lymphoblastic leukemia and cooperates with BLNK mutations.
Cancer Sci., in press (2021)
Sunami, Y., Yokoyama, T., Yoshino, S., Takahara, T., Yamazaki, Y., Harada, H. and Nakamura, T.
BCL11A promotes myeloid leukemogenesis by repressing PU.1 target genes.
Blood Adv., in press (2021)
Okumura, S., Konishi, Y., Narukawa, M., Sugiura, Y., Yoshimoto, S., Arai, Y., Sato, S., Yoshida, Y., Tsuji, S., Uemura, K., Wakita, M., Matsudaira, T., Matsumoto, T., Kawamoto, S., Takahashi, A., Itatani, Y., Miki, H., Takamatsu, M., Obama, K., Takeuchi, K., Suematsu, M., Ohtani, N., Fukunaga, Y., Ueno, M., Sakai, Y., Nagayama, S. and Hara, E.
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion.
Nat. Commun., 12, 5674 (2021)
Osako, T., Kurisaki-Arakawa, A., Dobashi, A., Togashi, Y., Baba, S., Shiozawa, S., Ishigame, H., Ishige, H., Ohno, S., Ishikawa, Y. and Takeuchi, K.
Distinct clinicopathologic features and possible pathogenesis of localized ALK-positive histiocytosis of the breast.
Am. J. Surg. Pathol., in press (2021)
Isoyama, S., Mori, S., Sugiyama, D., Kojima, Y., Tada, Y., Shitara, K., Hinohara, K., Dan, S. and Nishikawa, H.

Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal.

J. Immunother. Cancer, 9,  (2021)

 

more